Antibiotic stewardship combats antibiotic resistance by reducing inappropriate antibiotic 25 use. Stewardship policy should be guided by experimental stewardship interventions. 26 However, the design and interpretation of stewardship interventions is subject to 27 "spillover", in which the transmission of microbes between the control and intervention 28 population reduces the intervention's measured effect. Small-scale stewardship 29 experiments may therefore underestimate the effect of a larger-scale implementation. 30
Introduction 46
Antibiotic resistance is a major threat to public health (1). Outpatient antibiotic use, 47 which accounts for approximately 80% of human antibiotic use (2,3), is considered a 48 principal driver of antibiotic resistance in the community (4), and antibiotic stewardship 49 aims to mitigate antibiotic resistance (5-7) by reducing antibiotic use. US national 50 stewardship policy should be guided by evidence from experimental stewardship 51 interventions at smaller scales. For example, the results of interventions at the scale of 52 US states could be used to inform the design of national policy. However, antibiotic 53 resistance is a complex, temporally dynamic phenomenon (8-11), making the design 54 and interpretation of stewardship interventions challenging. 55
56
A key feature of antibiotic resistance is that it can be transmitted from person to person, 57 so that one person's risk of an antibiotic resistant infection depends on that person's 58 antibiotic use (12,13) as well as the rates of antibiotic use among that person's contacts 59 (14) . For example, one person's use of antibiotics increases the risk of an antibiotic 60 resistant infection among their family members (15-18). As an extreme example, 61 hospitalized patients with no recent antibiotic use can have a higher risk of resistance 62 than people in the community who use many antibiotics (19) because, in general, rates 63 of antibiotic use and resistance among hospitalized patients are high. A change in an 64 individual's use of antibiotics is therefore not an accurate predictor of the change in 65 antibiotic resistance that would follow from the same change in use if it occurred among 66 a larger group of people. Likewise, an intervention targeting a group of people might 67 have different effects depending on that population's interactions with other populations. 68
For example, if antibiotic use in one hospital changes, resistance might not change as 69 expected because resistant or susceptible bacteria can be transmitted, or "spill over", to 70 that hospital's patients in the community or in other hospitals. 71
72
The effect of susceptibility and resistance "spilling over" between populations during 73 stewardship interventions could theoretically be reduced by using larger populations. 74
Smaller populations tend to have more transmission with the surrounding populations 75 compared with larger populations, which tend to have more contacts within populations, 76 rather than between populations. Thus, the problem of "spillover" is mitigated when 77 studying larger populations. However, even hospitals are subject to spillover, as the 78 level of resistance in one hospital appears to be affected by resistance levels in nearby 79 hospitals as well as by antibiotic use rates in the surrounding communities (20-22). It is 80 therefore possible that even hospitals may be too small and too subject to spillover to 81 be accurate "laboratories" for stewardship. 82
83
We hypothesized that stewardship interventions at the level of US states, which are 84 large populations with relatively independent public health policies, may be subject to 85 substantially lower levels of spillover than individual-level or even hospital-level 86 interventions. We evaluated this hypothesis using mathematical models and cross-87 sectional data of antibiotic use and resistance. First, we use mathematical models of 88 antibiotic use and resistance to make quantitative predictions about the effect of 89 spillover between US states and European countries. Second, we search for signals of 90 spillover in observational data of antibiotic use and resistance in US states and 91 European countries. We chose to include European countries because, although our 92 goal was to evaluate whether states are accurate "laboratories" for US national policy, 93 the association between antibiotic use and antibiotic resistance has been previously 94 characterized in many ecological studies at the level of US states (23-25) and 95
European countries (26,27). Furthermore, many European countries are roughly similar 96 in size to US states and might provide useful context for any US results. 97 98 99 Methods 100
Dynamical model of antibiotic resistance 101
To examine how interactions between populations could theoretically affect the 102 association between antibiotic use and resistance, we use the within-host neutrality 103
(WHN) mathematical model presented by Davies et al. (28) and described in the 104 Supplemental Methods. Briefly, the model predicts the prevalence ρ of antibiotic 105 resistance that results from an antibiotic use rate τ in a single, well-mixed population. To 106 verify that conclusions drawn from the WHN model are not specific to the model 107 structure, we repeated all analyses with the "D-types" model of use and resistance (29). 108
We selected these two models because they demonstrate coexistence between 109 sensitive and resistant strains at equilibrium over a wide parameter space. Parameter 110 values and simulation methodology for both models are in the Supplemental Methods. 111
In the simulations, antibiotic use is measured as monthly treatments per capita and 112 resistance as the proportion of colonized hosts carrying resistant strains. 113
114
We adapted the WHN model, using a structured host population approach inspired by 115 Blanquart et al. (30) , to simulate a stewardship experiment in which an intervention 116 population has a lower antibiotic use rate "#$ than a control population with use rate 117 %&#$ . To determine how spillover affects the intervention's measured outcome, we 118 modulated the proportion ε of each population's contacts that are in the other 119 population. For ε = 0, the populations are completely separate. For ε = 0.5, contacts 120 across populations are just as likely as contacts within populations (Supplemental 121 Methods). We varied ε between 0 and 0.50, and we varied the difference in use Δ = 122 We excluded the S. pneumoniae resistance to β-lactams in US states from the analysis 151 because, in previous work using the same primary datasets, the point estimate for the 152 use-resistance relationship was negative (37). 153 154
Use-resistance relationships by populations' adjacency 155
To test the theoretical prediction that the same difference in antibiotic use will be 156 associated with smaller differences in antibiotic resistance when two populations (US 157 states or European countries) have stronger interactions, we tested whether the use-158 resistance association is weaker in adjacent pairs of populations, which presumably 159 have more cross-population contacts, compared to non-adjacent populations. Two 160 populations were considered adjacent if they share a land or river border (Supplemental 161 Methods). 162
163
We quantified the use-resistance association as the percentage point difference in 164 resistance (proportion of non-susceptible isolates) divided by the difference in antibiotic 165 use. We summarized use-resistance associations among adjacent pairs and non-166 adjacent pairs of populations using the median value. Because use-resistance 167 relationships between pairs of populations are correlated, we used the jackknife method 168 to compute confidence intervals on the difference in medians between groups. 169
170
In a sensitivity analysis, to account for the possibility that the use-resistance association 171 is not well-described using the simple difference in resistance proportions, we use the 172 log odds ratio of resistance as the numerator in the use-resistance association. 173 174
Use-resistance relationships by adjacency, accounting for confounders 175
We expected that analyzing use-resistance associations by adjacency might artificially 176 inflate the signal for spillover because determinants of antibiotic resistance aside from 177 antibiotic use are spatially correlated. For example, if temperature affects levels of 178 resistance (24), then the fact that adjacent populations tend to have similar climates 179 may cause those populations to have more similar resistances, mimicking spillover. To 180 partially account for these other determinants of resistance, we performed robust linear 181 regressions predicting the use-resistance relationship from adjacency (dichotomous 182 variable) as well as the differences in population density (38), per capita income (39), 183 and mean temperature (24) between the two populations (Supplemental Methods). 184
Regressions were computed using the rlm function in the MASS package (40) in R. 185
Confidence intervals on the adjacency-use interaction coefficient were computed using 186 the jackknife method described above. 187 188
Use-resistance associations by commuting fraction 189
Because adjacency might be too coarse measure of populations' interactions to detect 190 spillover, we repeated the analyses above, replacing the dichotomous adjacency 191 variable with "commuting fraction", which we defined as the number of individuals who 192 commute between the areas divided by the total number of workers in those two areas 193 (Supplemental Methods). We expected that this might be a better approximation of the 194 mathematical parameter ε, the fraction of a population's contacts that are in the other 195 population, that was varied in the theoretical models of use and resistance. In simulations of two populations, representing an intervention and control group, 202 interactions between the two groups attenuated the effect of the intervention (Figure 1) . 203
With increasing interaction strength, the same intervention, that is, the same difference 204 in antibiotic use between the populations, was associated with a smaller difference in 205 antibiotic resistance. The difference in resistance between populations increases with 206 the difference in antibiotic use (Figure 1d ), but the use-resistance association, 207 measured as the ratio of the difference in resistance to the difference in use, depends 208 strongly on the interaction strength ( Figure 1e ). Thus, spillover between populations 209 attenuates the measured use-resistance association. 210
211
The use-resistance association was sensitive to ε, the proportion of each population's 212 contacts that are in the other population, but depended on choice of the mathematical 213 model of use-resistance association (Supplemental Table 1 , Supplemental Figure 1 ). 214
For values as small as = 10 89 , a typical level of interaction between two US states or 215
European countries (Supplemental Figure 2) , the use-resistance association declined 216 by less than 1% with the WHN model but up to 20% for the "D-types" model. For = 217 1%, the use-resistance declined by approximately 30% in the WHN model and more 218 than 60% in the "D-types" model. In other words, the models predict that as few as 1% 219 of contacts need to be across populations, rather than within populations, to cause the 220 observed effect of an antibiotic stewardship intervention to shrink by one-third, or even 221 half. 222
223
To test whether spillover is important at the scale of US states or European countries, 224
we measured use-resistance associations between pairs of populations in 6 225 combinations of pathogen species, antibiotic class, and data source ( Figure 2 ). We 226 reasoned that, if spillover is relevant at these geographic scales, pairs of states or 227 countries with stronger interactions would have detectably weaker use-resistance 228 associations. 229
230
We first tested whether pairs of physically adjacent populations (e.g., Massachusetts 231 and Connecticut) had weaker use-resistance associations than non-adjacent 232 populations (e.g., Massachusetts and Alaska). In 5 of 6 pathogen/antibiotic/dataset 233 combinations, the median use-resistance association was smaller among adjacent 234 populations than among non-adjacent populations (Figure 3) . In 2 cases, the confidence 235 interval on the ratio of use-resistance associations among adjacent populations, 236 compared to non-adjacent populations, did not include zero (Supplemental Table 2 ). 237
First, for S. pneumoniae resistance to macrolides in the MarketScan/ResistanceOpen 238 dataset, use-resistance associations were 27% weaker (95% CI 6% to 49%) among 239 adjacent states compared to non-adjacent states. Second, for E. coli resistance to 240 quinolones in the Xponent/NHSN dataset, use-resistance associations were 50% 241 weaker (95% CI 27% to 73%) among adjacent states compared to non-adjacent states. 242
Results were similar when using a different metric of the use-resistance association 243 (Supplemental Table 3 ). 244 245 We next checked that determinants of antibiotic resistance aside from antibiotic use 246 were not artificially amplifying spillover, making differences in the use-resistance 247 association between adjacent and non-adjacent pairs larger. We performed robust 248 regressions, predicting the use-resistance association from adjacency while controlling 249 for the differences in other covariates that are established determinants of resistance 250 levels. Results were almost identical when including these covariates (Supplemental 251 Table 4 ), suggesting that these spatially-correlated covariates of resistance are not 252 driving the spillover signal we observed. 253 254 Finally, we checked whether adjacency was too coarse a measure for interactions 255 between populations by replacing the dichotomous adjacency variable with a 256 continuous variable, the "commuting fraction", defined as the proportion of residents of a 257 pair of populations that commute to the other population (Figure 4) . In 2 258 dataset/pathogen/antibiotic combinations, the confidence interval around the spillover 259 signal did not include zero ( Supplemental Table 5 ). First, for E. coli resistance to 260 quinolones in the MarketScan/ResistanceOpen dataset, a modest commuting fraction 261 comparable to the effect of adjacency (10 89 ) was associated with a 0.9% decrease 262 (95% CI 0.5% to 1.3%) in use-resistance associations, compared to pairs of states with 263 no inter-state commuters. Second, S. pneumoniae resistance to macrolides in the 264 ECDC dataset, that same commuting fraction was associated with a 12% decrease 265 (95% CI 3% to 20%) in use-resistance associations. 266 267 268
Discussion 269
We used theoretical models to show that interactions between a control and intervention 270 group can attenuate the reduction in antibiotic resistance expected from an antibiotic 271 stewardship intervention. The quantitative relationship between the extent of inter-272 population interactions and the attenuation of the use-resistance association was 273 dependent on the precise theoretical model used. However, we found that, in two 274 models of the use-resistance association, having on the order of 1% of interactions 275 between a control and intervention population was sufficient to attenuate the observed 276 effect of theoretical stewardship intervention by 50%, relative to a situation where the 277 two populations were completely isolated. Thus, in theory, even small numbers of 278 interactions could lead to a substantial underestimation of the potential reduction in 279 antibiotic resistance that would follow from a reduction in antibiotic use, compared to the 280 same reduction in use implemented in a completely isolated population. 281
282
In observational antibiotic use and resistance data in 3 pathogen-antibiotic combinations 283 across 3 datasets, we found that point estimates of the spillover effect varied from as 284 small as 1% to as large as 50%. In general, however, the confidence intervals on these 285 estimates were wide, encompassing zero in most cases. We therefore did not find 286 strong evidence to support our hypothesis, that spillover would have minimal effects at 287 the level of US states. In fact, our results suggest that an experimental stewardship 288 intervention conducted at the level of a US states might underestimate, by as much as 289 50%, the effect that the same intervention would have on resistance if it were 290 implemented at a national scale. It is unclear if US states can be used as accurate 291 "laboratories" of the effects of national stewardship policy. 292
293
Our study has multiple limitations. First, we used observational data to address 294 questions about the design of outpatient stewardship interventions, which requires 295 interpreting the theoretical results and ecological data as if the association between 296 antibiotic use and resistance were causal and deterministic. In fact, antibiotic resistance 297 is associated with factors beyond antibiotic use (24,42), and we used only a limited 298 number of determinants of resistance besides antibiotic use in our analyses. 299 300 Second, decreases in the use of an antibiotic may not necessarily lead to declines in 301 resistance to that antibiotic in a target pathogen (10,43-45). We do not address co-302 resistance and cross-selection (46,47), and we assumed that resistance equilibrates on 303 a timescale comparable to an intervention. Previous research has shown that resistance 304 among E. coli, S. pneumoniae, N. gonorrhoeae and other organisms can respond to 305 changes in antibiotic use on the timescale of months (48-51), but the expected delay 306 between a perturbation to antibiotic use and the resulting change in resistance remains 307 a subject of active study (11, 48, 52, 53) . 308 309 Finally, analyses based on administrative entities like US states, although logistically 310 attractive "laboratories" of stewardship, will always be difficult to interpret because 311 administrative entities average over important dimensions of population structure like 312 age (54), sexual networks (55), and race/ethnicity (56). Thus, use-resistance 313 associations measured across states and countries may be different from those that 314 appear among geographically-proximate populations with dissimilar antibiotic use rates, 315 such as the sexes (57) and racial/ethnic groups (58). We might have come to different 316 conclusions about the role of spillover if we used different types of populations for 317 analysis. 
